MedTrace Logo

Shafer Width and Girth: The Use of Injectable Fillers for Penile Enhancement

NCT04755634 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-05-22

No results posted yet for this study

Summary

Injectable filler will be performed by Principal Investigator under sterile conditions for the enhancement of girth and surface area of the penis.

Conditions

  • Micropenis

Interventions

DEVICE

Hyaluronic Acid

Injectable

Sponsors & Collaborators

  • Shafer Clinic Fifth Avenue

    lead NETWORK

Principal Investigators

  • David Shafer, MD · Shafer Clinic Fifth Avenue

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-23
Primary Completion
2024-06-27
Completion
2024-06-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04755634 on ClinicalTrials.gov